Related by context. All words. (Click for frequent words.) 73 ovarian cancer 73 colorectal cancer 72 breast cancer recurrence 72 prostate cancer 71 breast cancer 71 postmenopausal breast cancer 70 invasive breast cancer 70 colon cancer 69 premenopausal breast cancer 67 endometrial cancers 67 breast cancers 66 endometrial hyperplasia 66 lobular breast cancer 66 cardiovascular disease 65 rectal cancer 65 pre menopausal 65 preterm delivery 64 bladder cancer 64 heart disease 64 prostate cancers 64 lung cancer 64 oophorectomy 64 ovarian cancers 64 breast tumors 64 colorectal adenomas 64 post menopausal 63 liver cancer 63 colorectal cancers 63 localized prostate cancer 63 atypical hyperplasia 63 HER2 positive breast cancer 63 cancers 63 gastric cancer 62 metastatic prostate cancer 62 lobular cancer 62 colorectal cancer CRC 62 uterine cancer 62 pancreatic cancer 62 preeclampsia 62 lobular carcinoma 62 uterine cancers 62 adenomas 61 postmenopausal women 61 bladder cancers 61 colon cancers 61 premenopausal 61 bowel cancers 61 oesophageal cancer 61 HNSCC 61 gastrointestinal cancers 61 melanoma 61 ductal breast cancer 60 colorectal adenoma 60 bowel cancer 60 malignancies 60 colorectal polyps 60 rectal cancers 60 colon tumors 60 ovarian tumors 60 laryngeal cancer 60 esophageal cancer 60 colon polyps 60 BRCA2 mutations 59 estrogen receptor negative 59 BRCA1 mutations 59 colorectal tumors 59 epithelial ovarian cancer 59 hereditary breast cancer 59 venous thromboembolism 59 pre eclampsia 59 cervical cancer 59 premenopausal women 59 ductal cancer 59 metabolic syndrome 59 folate supplementation 59 coronary disease 59 testicular cancers 59 spontaneous preterm delivery 59 endometrial carcinoma 59 prostate pancreatic 59 hormone therapy estrogen 59 tamoxifen 59 venous thrombosis 59 advanced adenoma 59 endometrial 59 esophageal cancers 58 endometriosis ovarian cysts 58 prostate cancer CaP 58 polycystic ovary syndrome PCOS 58 BRCA mutations 58 lung tumors 58 osteoporosis 58 breast endometrial 58 cancer 58 adenoma 58 prostate cancer CRPC 58 oropharyngeal cancer 58 colorectal neoplasia 58 cardiovascular mortality 58 ovulatory infertility 58 breast carcinoma 58 estrogen therapy 58 contralateral breast cancer 58 metastatic disease 58 Breast cancer 58 hormone therapy 58 metastatic cancer 57 recurrent ovarian cancer 57 gestational diabetes 57 coronary artery disease 57 prostrate cancer 57 nonmelanoma skin cancer 57 mammographic density 57 distant metastases 57 cardiovascular disease CVD 57 perimenopausal women 57 malignant melanoma 57 metastatic breast cancer 57 recurrent miscarriage 57 liver fibrosis 57 uterine tumors 57 preterm deliveries 57 ischemic stroke 57 spontaneous preterm birth 57 tumor recurrence 57 atherosclerosis 57 esophageal adenocarcinoma 57 distal colon cancer 57 colorectal carcinoma 57 cerebral infarction 57 Ovary removal 57 coronary heart 57 BRCA mutation 57 pancreatic adenocarcinoma 57 cutaneous melanoma 57 gynecological cancers 57 postmenopausal 57 vasomotor symptoms 57 subclinical hypothyroidism 57 nonmelanoma skin cancers 57 menopausal hormone therapy 57 benign breast 57 advanced adenomas 56 pancreatic cancers 56 Uterine cancer 56 atypia 56 estrogen 56 polycystic ovary syndrome 56 alcoholic cirrhosis 56 uterine ovarian 56 CaP 56 undergone hysterectomy 56 basal cell carcinomas 56 endometriosis 56 anovulatory infertility 56 gynecologic cancer 56 knee osteoarthritis 56 malignancy 56 gallstone disease 56 adenocarcinoma 56 bilateral oophorectomy 56 lung cancers 56 BRCA gene mutations 56 peritoneal cancer 56 colorectal 56 NAFLD 56 PSA velocity 56 pleural mesothelioma 56 pre cancerous lesions 56 dose aspirin 56 tibolone 56 polyp recurrence 56 folate intake 56 PSADT 56 precancerous lesions 56 brain metastases 56 nonsmall cell lung cancer 56 renal cell carcinoma 56 cognitive decline 56 prostate cancer PCa 56 mammary tumors 56 cervical lesions 55 tamoxifen therapy 55 recurrent VTE 55 ovarian 55 postoperative pulmonary 55 hepatocellular carcinoma HCC 55 CMV disease 55 Testicular cancer 55 colon breast 55 hormone receptor positive 55 gynecologic cancers 55 adenoma recurrence 55 gastric cancers 55 vertebral fracture 55 mutated BRCA1 55 coronary calcification 55 phytoestrogens 55 seminoma 55 Ovarian cancer 55 tumors 55 epithelial ovarian 55 Estrogen therapy 55 postoperative mortality 55 adjuvant radiation 55 basal cell carcinoma BCC 55 prostate tumor 55 menopause 55 anastrozole 55 invasive cervical cancer 55 chronic prostatitis 55 elevated CRP 55 H. pylori infection 55 venous blood clots 55 Premenopausal women 55 chemopreventive agent 55 endometrial kidney 55 androgen deprivation therapy 55 BRCA mutation carriers 55 familial adenomatous polyposis 55 Endometrial cancer 55 isoflavones 55 androgen deprivation 55 chlamydial infection 55 folic acid intake 55 skin cancers 55 premature menopause 55 operable breast cancer 55 haemorrhagic stroke 55 lung adenocarcinoma 55 thrombotic events 55 prostate cancer mCRPC 55 atherosclerotic disease 55 menopausal symptoms 54 neoplasia 54 salpingo oophorectomy 54 soy isoflavones 54 prostate tumors 54 symptomatic fibroids 54 urothelial cancer 54 basal cell nevus syndrome 54 carotid atherosclerosis 54 situ LCIS 54 ductal carcinomas 54 hip fracture 54 MetS 54 squamous cell cancers 54 breast cancer metastasis 54 breast tissue 54 bone metastasis 54 disease NAFLD 54 GnRH agonists 54 postoperative delirium 54 gestational hypertension 54 thromboembolic events 54 pre cancerous polyps 54 T1DM 54 Stomach cancer 54 urinary bladder cancer 54 colorectal polyp 54 gynecological cancer 54 thromboembolic disease 54 prophylactic mastectomy 54 testicular cancer 54 BRCA gene mutation 54 intestinal polyps 54 postmenopausal hormone 54 endogenous estrogen 54 ovarian lung 54 SHBG 54 estrogen receptor positive 54 Adjuvant chemotherapy 54 estrogen deficiency 54 thrombosis 54 basal cell carcinoma 54 adjuvant radiotherapy 54 sudden cardiac death 54 bone mineral 54 selenium supplementation 54 oesophageal adenocarcinoma 54 folate deficiency 54 ovarian pancreatic 54 esophageal squamous cell carcinoma 54 postmenopausal hormone therapy 54 colon rectal cancer 54 leiomyomas 54 poorer prognosis 54 invasive ductal 54 Cholangiocarcinoma 54 magnesium intake 54 gum disease 54 pCR 54 beta carotene supplements 54 distant metastasis 54 breast tenderness 54 EBRT 54 Gastric cancer 54 modifiable risk 54 progestins 54 Hormone therapy 54 PCa 54 liver metastasis 54 colorectal cancer incidence 54 relapsed ovarian cancer 54 medullary thyroid cancer 54 thromboembolism 54 Leitzmann 54 aneuploidy 54 precursor lesions 53 ALCL 53 systemic lupus erythematosus SLE 53 atypical ductal hyperplasia 53 lymphoma 53 brain shrinkage 53 ovaries removed 53 renal dysfunction 53 fibroadenomas 53 folic acid 53 BRCA2 mutation carriers 53 secondary hyperparathyroidism 53 hormonal therapy 53 hepatocellular carcinoma 53 carcinoma 53 testicular germ cell 53 Barrett esophagus 53 Prostate cancer 53 malignant pleural mesothelioma 53 osteoporotic fractures 53 neural tube defects 53 SHBG levels 53 insulin resistance 53 acute myelogenous leukemia AML 53 axillary dissection 53 spine fractures 53 subclinical hyperthyroidism 53 fallopian tube carcinoma 53 serum PSA 53 atherosclerotic lesions 53 ovarian carcinoma 53 Hepatocellular Carcinoma HCC 53 ALND 53 bowel polyps 53 breast cancer Narod 53 squamous cell 53 serous ovarian cancer 53 carotid stenosis 53 HER2 positive 53 serum calcium levels 53 Non Hodgkin lymphoma 53 CMV infection 53 breast colon 53 postoperative AF 53 prostate adenocarcinoma 53 albuminuria 53 benign growths 53 antigen PSA 53 metastatic colon cancer 53 elevated LDL cholesterol 53 ovarian uterine 53 pelvic malignancies 53 adjuvant therapy 53 pancreatic lung 53 gamma tocopherol 53 precancerous cells 53 lymphedema 53 urinary symptoms 53 statins 53 nonalcoholic steatohepatitis NASH 53 recurrent miscarriages 53 prostate 53 thyroid hormone levels 53 placental malaria 53 vascular disease 53 preoperative chemotherapy 53 dysglycemia 53 VTE 53 BRCA2 gene mutation 53 BRCA2 mutation 53 adenomatous polyps 53 neural tube birth defects 53 hydroxyvitamin D levels 53 breast ovarian 53 malignant growths 53 aromatase inhibitors AIs 53 Folic acid supplements 53 recurrent stroke 53 osteoporotic 53 cisplatin chemotherapy 53 Radical prostatectomy 53 estrogen progestin therapy 53 tumor histology 53 metastases 53 bone density 53 postmenopausal hormone replacement 53 prophylactic mastectomies 53 Alzheimer disease 53 adenomatous 53 Breast Cancer Risk 53 folate 53 HPV infection 53 ovarian cervical 53 venous thromboembolic events 53 transferrin saturation 53 elevated depressive symptoms 53 invasive carcinoma 53 alpha carotene 53 vitamin D deficiency 53 liver metastases 53 squamous cell carcinomas 53 de ath 53 metastatic lung cancer 53 Oral contraceptives 53 cardio vascular disease 53 cancerdefine 53 thiazide diuretics 53 calcium supplementation 52 polycystic ovarian syndrome 52 AVODART 52 testosterone supplementation 52 malignant lymphoma 52 impair fertility 52 oral contraceptive pills 52 polyp detection 52 HNPCC 52 abnormal uterine bleeding 52 asymptomatic carotid stenosis 52 cranial irradiation 52 osteopenia 52 Androgen deprivation therapy 52 ovulatory cycles 52 precancerous colon polyps 52 atopic disease 52 bacterial vaginosis 52 periodontal disease 52 cardiovascular disease hypertension 52 vaginal atrophy 52 colo rectal cancer 52 bone resorption 52 premenstrual syndrome PMS 52 COPD 52 colon rectal 52 IV melanoma 52 preventive mastectomies 52 intravenous bisphosphonates 52 childhood leukemia 52 periodontitis 52 neural tube defect 52 DCIS 52 peritoneal carcinomatosis 52 proliferative diabetic retinopathy 52 metastatic gastric 52 prolongs survival 52 Prostate Cancer 52 Barrett Esophagus 52 AAT deficiency 52 PSA screening 52 mammographic breast density 52 choriocarcinoma 52 neoplasia PIN 52 polycystic ovarian syndrome PCOS 52 disease progression 52 situ DCIS 52 Hilakivi Clarke 52 malignant tumors 52 mammary cancers 52 cardiotoxicity 52 HER2 positive cancers 52 PAOD 52 multiple myeloma 52 gene variant 52 subclinical atherosclerosis 52 undergoing hysterectomy 52 liver disease 52 Cristofanilli 52 arterial calcification 52 clinically localized prostate 52 knee OA 52 prostate cancer HRPC 52 node metastases 52 glucose intolerance 52 hypercholesterolemia 52 ABCB1 52 neoadjuvant therapy 52 polycystic ovaries 52 squamous cell carcinoma 52 gynecologic malignancy 52 BRCA carriers 52 anal cancers 52 prostate specific antigen 52 brain tumors 52 zoledronic acid 52 thyroid cancers 52 genistein 52 prostate carcinoma 52 contralateral breast 52 precancerous cervical 52 CLA supplementation 52 serum phosphate 52 Wilms tumor 52 pancreatic prostate 52 pre cancerous growths 52 leukemia AML 52 recurrent ovarian 52 estrogen progestin combination 52 LQTS 52 Chlamydia infection 52 denser breasts 52 undergoing radical prostatectomy 52 mycophenolate mofetil 52 abnormal mammograms 52 BRCA1 52 prostate colon 52 precancerous polyps 52 upper gastrointestinal bleeding 52 endothelial dysfunction 52 hormone deprivation 52 p# mutations 52 hepatocellular cancer 52 familial pancreatic cancer 52 colorectal liver metastases 52 gene variation 52 renal cell carcinomas 52 preterm births 52 grade gliomas 52 phytoestrogen 52 axillary lymph nodes 52 aromatase inhibitors 52 uterine fibroids 52 locoregional recurrence 52 MGUS 52 biochemical recurrence 52 endometrial tumors 52 postoperative atrial fibrillation 52 urinary incontinence 52 thrombotic complications 51 lymph node metastases 51 familial hypercholesterolemia 51 urinary tract symptoms LUTS 51 folic acid supplements 51 Bladder cancer 51 chlamydia infection 51 neoadjuvant chemotherapy 51 ductal carcinoma 51 nodal metastasis 51 abnormal mammogram 51 papillary thyroid cancer 51 GSTT1 51 cervical carcinoma 51 prostate specific 51 recurrent prostate cancer 51 invasive ductal breast cancer 51 uveal melanoma 51 preterm birth 51 noncancerous tumors 51 osteoporotic fracture 51 breast conserving 51 tumor progression 51 neoplasias 51 coronary artery calcium 51 noncarriers 51 myocardial infarction MI 51 homocysteine levels 51 undergone radical prostatectomy 51 lipid abnormalities 51 folic acid supplementation 51 colorectal neoplasms 51 thyroid function 51 ovarian hormones 51 hormonal therapies 51 brain atrophy 51 PCOS 51 endometrial lining 51 APOL1 51 cervical dysplasia 51 Menopausal hormone therapy 51 precancerous cervical lesions 51 dexrazoxane 51 BRCA1 gene 51 antiestrogen 51 neoplasms 51 myeloid leukemia 51 improves insulin sensitivity 51 vitamin D supplementation 51 nonhormonal 51 urate levels 51 squamous cell carcinoma SCC 51 invasive lobular carcinoma 51 BRCA1 mutation 51 sarcomatoid 51 lung metastasis 51 squamous cell lung cancer 51 statin therapy 51 intensive statin therapy 51 mammary cancer 51 neoadjuvant treatment 51 glioma 51 carotid plaques 51 Estrogens 51 sodium valproate 51 Heavy menstrual bleeding 51 Colorectal cancer 51 slow metabolizers 51 Adenocarcinoma 51 NSCLC 51 invasive ductal carcinoma 51 androgen suppression therapy 51 cardiovascular 51 HDL cholesterol 51 Lung cancer 51 Ophena 51 mild gestational diabetes 51 genetic variant 51 lymph node removal 51 lobular involution 51 cardiorespiratory fitness 51 adjuvant chemotherapy 51 Lp PLA2 51 cardiovascular diseases 51 diabetes mellitus DM 51 hormone receptor negative 51 ticlopidine 51 oral bisphosphonates 51 metastatic renal cell carcinoma 51 Colon Cancer 51 angiosarcoma 51 contrast induced nephropathy 51 vitamin B# deficiency 51 renal tumors 51 thromboembolic 51 nonvertebral fractures 51 perioperative morbidity 51 carcinoid tumor 51 prostate ovarian 51 plus progestin hormone 51 hip fractures 51 irregular menstrual cycles 51 anal cancer 51 GBA mutations 51 cardiac dysfunction 51 Dr Zorbas 51 breast cancer recurrences 51 olaparib 51 diabetes 51 cryptorchidism 51 lymph node involvement 51 abiraterone 51 underwent prostatectomy 51 adiponectin levels 51 chronic lymphocytic leukemia CLL 51 cruciferous vegetables 51 faulty BRCA genes 51 prophylactic oophorectomy 51 postmenopausal hormones 51 pulmonary metastases 51 dietary folate intake 51 paclitaxel eluting stents 51 fatty liver disease 51 trastuzumab 51 abdominal fat 51 Endometrial 51 pelvic lymphadenectomy 51 CHD 51 curable cancers 51 fetal malformations 51 placenta praevia 51 Tamoxifen 51 atherothrombotic events 51 parkinsonism 51 Prostate Cancer Prevention 51 ovary removal 51 exemestane 51 obese postmenopausal 51 Pancreatic Cancer 51 nocturnal hypoglycaemia 51 postmenopause 51 calcitriol 51 cardio metabolic 51 Postmenopausal 51 carotid IMT 51 prostate carcinogenesis 51 obstetric complications 51 Carcinoma 51 taxane therapy 51 Prostate Specific Antigen PSA 51 nonfasting triglyceride levels 51 caffeinated coffee 51 adenocarcinomas 51 dose ionizing radiation 51 kidney dysfunction 51 pancreatic ovarian 51 basal cell cancers 51 vitamin E 51 carotid plaque 51 micrometastases 51 circulating estrogens 51 antidiabetic medication 51 shorter telomeres 51 anthracyclines 51 CIN3 51 hormone estrogen 51 gastric adenocarcinoma 51 testicular tumors 51 Tavocept 51 atrial fibrillation 51 CVD mortality 50 homocysteine concentrations 50 nonmetastatic 50 RBP4 levels 50 dietary antioxidants 50 CHD mortality 50 CC genotype 50 preventive mastectomy 50 PHPT 50 nonpregnant women 50 basal cell skin 50 aromatase inhibitor therapy 50 leukemia ALL 50 triglyceride concentrations 50 bisphosphonates 50 bone metastases 50 ApoE4 gene 50 locoregional 50 cetuximab Erbitux 50 phytoestrogen intake 50 rheumatoid arthritis RA 50 antiplatelet therapy 50 vulvar cancers 50 cabazitaxel 50 KIF6 carriers 50 estrogen metabolites 50 bladder tumors 50 refractory ovarian cancer 50 microvascular complications 50 APOE e4 50 cranial radiation 50 carcinogenesis 50 glandular tissue 50 obstructive coronary artery 50 bone fracture 50 GSTP1 50 chemoradiotherapy 50 deCODE BreastCancer TM 50 carcinoid cancer 50 narcolepsy cataplexy 50 diabetes mellitus 50 LUTS 50 gestational diabetes mellitus 50 lignan intake 50 POAG 50 overt hepatic encephalopathy HE 50 melanomas 50 abnormal cervical 50 leukaemias 50 venous thromboembolism VTE 50 myocardial infarction 50 calcium intake 50 BRCA1 mutation carriers 50 beta blocker therapy 50 MS relapses 50 folate supplements 50 microalbuminuria 50 anti androgen 50 adiponectin 50 artery calcification 50 statin medications 50 spontaneous preterm births 50 Raloxifene 50 thyroid cancer 50 urothelial carcinoma 50 nasopharyngeal carcinoma 50 prognostic variables 50 Metastases 50 chromosomal abnormalities 50 precancerous condition 50 tumor subtypes 50 pancreatic NET 50 PARP inhibition 50 Uterine fibroids 50 post thrombotic syndrome 50 serum vitamin D 50 Hodgkin lymphoma HL 50 elevated triglyceride levels 50 abnormal Pap test 50 BRCA2 carriers 50 enlarged prostates 50 Soy isoflavones 50 BRCA deficient 50 colon adenomas 50 lymphomas 50 metabolic syndrome MetS 50 autoantibody positive 50 chemoradiation 50 gastric carcinoma 50 Malignant Melanoma 50 plus progestin 50 grade glioma 50 N telopeptide 50 Helicobacter pylori infection 50 Colon polyps 50 intracerebral hemorrhage 50 paricalcitol 50 cervical intraepithelial neoplasia 50 juvenile idiopathic arthritis 50 adjuvant therapies 50 HPV infections 50 Wactawski Wende 50 bone thinning 50 retinopathy 50 abdominal adiposity 50 thromboembolisms 50 adrenal function 50 virologic failure 50 colorectal pancreatic 50 oestradiol 50 Ductal carcinoma 50 differentiated thyroid 50 DVT PE 50 visceral fat 50 oral contraception 50 male hormones androgens 50 Doxil ® 50 abnormal growths 50 microvascular disease 50 liver cirrhosis 50 HER2 overexpression 50 preterm labor 50 Clinical Endocrinology & 50 bacterial vaginosis BV 50 estrogen metabolism 50 metastatic tumors 50 chorioamnionitis 50 thyroid dysfunction 50 osteopenic 50 melanoma tumors 50 valproate 50 hirsutism 50 renal carcinoma 50 singleton pregnancy 50 breast uterine 50 PGDH 50 premalignant lesions 50 premalignant 50 parathyroid 50 medically inoperable 50 onset Alzheimer disease 50 cardiovascular morbidity 50 untreated celiac disease 50 chronic periodontitis 50 hot flashes 50 T2DM 50 chemoprevention 50 selenium supplements 50 hemorrhagic complications 50 frequently benign tumor 50 insulin sensitivity 50 sentinel lymph node biopsy 50 varicocele 50 recurrent metastatic 50 microbleeds 50 uterine rupture 50 metachronous 50 systemic lupus erythematosus 50 dementia 50 macrovascular 50 GSTM1 50 specific antigen PSA 50 cirrhotic patients 50 sFlt 1 50 melanoma skin 50 pancreatic neuroendocrine tumors 50 SHPT 50 prostate cancer AIPC 50 severe hypoglycemia 50 HIV infection 50 abdominal obesity 50 colorectal breast 50 arterial stiffening 50 prostate breast 50 IV bisphosphonates 50 atypical fractures 50 hepatic fibrosis 50 axillary lymph node dissection 50 BRCA 50 urolithiasis 50 BRCA2 50 castration resistant prostate cancer 50 lipoprotein 50 axillary node dissection 50 transitional cell carcinoma 50 naturally occurring estrogen 50 yearly mammograms 50 hypertension 50 calcium supplements 50 FGFR2 50 carcinomas 50 IUGR 50 recurrent NSCLC 50 LHRH receptor positive 50 bile duct cancer 50 herpes zoster 50 sporadic ALS 49 squamous cell cancer 49 myelodysplastic syndrome MDS 49 estradiol 49 gastric cardia 49 cerebral microbleeds 49 Colorectal cancers 49 gene variants 49 acute myeloid leukemia 49 hematopoietic cancers 49 oral contraceptives 49 conjugated equine estrogen 49 lymphadenectomy 49 perioperative mortality 49 oral bisphosphonate 49 metastatic bladder 49 cognitive impairment 49 ovarian function 49 CIN2 + 49 familial ALS 49 asymptomatic 49 HER2 positive metastatic breast 49 dietary fat 49 clodronate 49 benign prostatic hypertrophy 49 invasive lobular 49 onset sepsis 49 chemoprevention trials 49 STRIDE PD 49 primary ovarian insufficiency 49 hormone refractory prostate cancer 49 meningioma 49 cervical vaginal 49 advanced neoplasia 49 myelofibrosis MF 49 hip BMD 49 blood clots 49 malignant mesothelioma 49 trans palmitoleic acid 49 androgen therapy 49 inflammatory polyarthritis 49 cisplatin 49 precancerous polyp 49 FGFR2 gene 49 telomere lengths 49 C reactive protein 49 precancerous growths 49 parous women 49 gynecomastia 49 flutamide 49 progesterone receptor negative 49 EGFR mutations 49 postpartum hemorrhage 49 systemic scleroderma 49 lymph node metastasis 49 congenital abnormalities 49 ovarian hyperstimulation syndrome 49 metastatic RCC 49 RBP4 49 LDL cholesterol levels 49 hepatitis C infection 49 preterm infants 49 ARIMIDEX 49 menarche 49 lung colorectal 49 insulin resistance syndrome 49 peripheral artery disease 49 androgen deficiency 49 postmenopausal osteoporosis 49 breast asymmetry 49 laryngeal cancers 49 grade cervical intraepithelial 49 triglyceride levels 49 5-FU/LV 49 SRBD 49 osteosarcomas 49 relapsing remitting multiple sclerosis 49 androgen ablation 49 lupus nephritis 49 preterm babies 49 non Hodgkin lymphoma 49 systolic dysfunction 49 recurrent preterm birth 49 genes BRCA1 49 pathologic fractures 49 left ventricular dysfunction 49 bronchopulmonary dysplasia 49 metastatic colorectal 49 gene mutation 49 APOE gene 49 prednisone prednisolone 49 hormonal treatments 49 gestational diabetes mellitus GDM 49 abnormal Pap smears 49 Hashimoto thyroiditis 49 beta carotene supplementation 49 amenorrhea 49 Bairey Merz 49 vitamin D intake